National Laboratories Excellence program (under the National Tumor Biology Laboratory
Project(NLP-17)
Nemzeti Népegészségügyi Stratégiával Összefüggő Feladatok((IV/4925/2021/EKF))
Skin melanoma is not among malignancies with the highest incidences and mortalities
worldwide; however, the observed constant increase in newly diagnosed cases is troublesome.
According to the database of the Hungarian Cancer Registry, the number of newly reported
cases doubled between 2001 and 2019, which is consistent with international data.
Notwithstanding, within the same interval, Hungarian mortality did not change significantly
according to the database of the Hungarian Statistical Office, which is in contrast
to international trends. The increasing incidence together with unchanging mortality
resulted in better survival rates and hence more favorable follow-up data in our country.
Advancements in secondary prevention programs and better efficacy of modern therapeutic
interventions in the last decade may have contributed to the observed improvement
in the survival rates of Hungarian melanoma patients.
